(RTTNews) - Wednesday, United Therapeutics Corporation (UTHR) announced that the U.S. District Court for the District of Delaware ruled that Liquidia Technologies (LQDA) infringed claims 1 and 14 of United Therapeutics' U.S. Patent No. 11,826,327, which covers the treatment of pu
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.